Latest immunotherapy news
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
posted June 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
posted May 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers .jpg)
Cancer Survivors Have Lower Levels of Physical Activity 
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
